Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by flt3 ligand and tacrolimus

Transplantation

Volumn 63, Issue 9, 1997, Pages 1193-1199

  Iyengar, Anand R ^a   Bonham, C Andrew ^a   Antonysamy, Mary A ^a   Subbotin, Vladimir M ^a   Khanna, Ajai ^a   Murase, Noriko ^a   Rao, Abdul S ^a   Starzl, Thomas E ^a   Thomson, Angus W ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TACROLIMUS;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHIMERA; CHO CELL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECIPIENT; SPLEEN CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BONE MARROW TRANSPLANTATION; CHO CELLS; CRICETINAE; DNA; DRUG THERAPY, COMBINATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOSUPPRESSIVE AGENTS; MEMBRANE PROTEINS; MICE; MICE, INBRED STRAINS; T-LYMPHOCYTES, CYTOTOXIC; TACROLIMUS; TISSUE DONORS; TRANSPLANTATION CHIMERA;

EID: 0031009365     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199705150-00001     Document Type: Article

References (47)

1. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992; 339: 1579.
2. Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole organ transplantation: the basis of graft acceptance. Hepatology 1993; 17: 1127.
3. Starzl TE, Demetris AJ, Murase N, Trucco M, Thomson AW, Rao AS. The lost chord: microchimerism and allograft survival. Immunol Today 1996; 17: 577.
4. Demetris AJ, Murase N, Fujisaki S, Fung JJ, Rao AS, Starzl TE. Hematolymphoid cell trafficking, microchimerism, and GVHD reactions after liver, bone marrow, and heart transplantation. Transplant Proc 1993; 25: 3337.
5. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ, Starzl TE. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 1994; 19: 916.
6. Thomson AW, Lu L, Murase N, Demetris AJ, Rao AS, Starzl TE. Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells 1995; 13: 622.
7. Fontes P, Rao AS, Demetris AJ, et al. Augmentation with bone marrow of donor leukocyte migration for kidney, liver, heart and pancreas islet transplantation. Lancet 1994; 344: 151.
8. Garcia-Morales R, Esquenazi V, Zucker K, et al. An assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry. Transplantation 1996; 62: 1149.
9. Starzl TE, Demetris AJ, Murase N, Thomson AW, Trucco M, Ricordi C. Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today 1993; 14: 326.
10. Metcalf D. The molecular control of cell division, differentiation, commitment and maturation in hematopoietic cells. Nature 1989; 339: 27.
11. Whetton AD, Dexter TM. Myeloid haemopoietic growth factors. Biochim Biophys Acta 1989; 989: 111.
12. Moore MAS. Clinical implications of positive and negative hematopoietic stem cell regulators. Blood 1991; 78: 1.
13. Metcalf D. Hematopoietic regulators: redundancy or subtlety? Blood 1993; 82: 3515.
14. Lyman SD, James L, Bos TV, et al. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell 1993; 75: 1157.
15. Hannum C, Culpepper J, Campbell D, et al. Ligand for FLT3/ FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 1994; 368: 643.
16. Lyman SD, James L, Johnson L, et al. Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. Blood 1994; 83: 2795.
17. Jacobsen SEW, Okkenhaug C, Myklebust J, et al. The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interactions with interleukin (IL)-11, IL-12, and other hematopoietic growth factors. J Exp Med 1995; 181: 1357.
18. - cells and maintains progenitor cells in vitro. Blood 1996; 87: 3563.
19. Muench MO, Roncarolo MG, Menon S, et al. FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood 1995; 85: 963.
20. Maraskovsky E, Brasel K, Teepe M, et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med 1996; 184: 1953.
21. Brasel K, McKenna HJ, Charrier K, Morrissey P, Williams DE, Lyman SD. Mobilization of peripheral blood progenitor cells with Flt3 ligand. Blood 1995; 86: 463 [Abstract].
22. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
23. Ouspenskaia MV, Johnston DA, Roberts WM, Eztrov Z, Zipf TF. Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: a description of the method and the principles involved. Leukemia 1995; 9: 321.
24. Thomson AW, Lu L, Subbotin VM, et al. In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients. Transplantation 1995; 59: 544.
25. Naparstek E, Ohana M, Greenberger JS, Slavin S. Continuous intravenous administration of rmGM-CSF enhances immune as well as hematopoietic reconstitution following syngeneic bone marrow transplantation in mice. Exp Hematol 1993; 21: 131.
26. Atkinson K, Matias C, Guiffre A, et al. In vivo administration of granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage CSF, interleukin-1 (IL-1), and IL-4, alone and in combination after allogeneic murine hematopoietic stem cell transplantation. Blood 1991; 77: 1376.
27. Tavassoli M, Konno M, Shiota Y, Omoto E, Minguell JJ, Zanjani ED. Enhancement of the grafting efficiency of transplanted marrow cells by preincubation with interleukin-3 and granulocyte-macrophage colony-stimulating factor. Blood 1991; 77: 1599.
28. Lu L, Rudert WA, Qian S, et al. Growth of donor-derived dendritic cells from the bone marrow of liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med 1995; 182: 379.
29. Murase N, Starzl TE, Tanabe M, et al. Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to Brown Norway rats. Transplantation 1995; 60: 158.
30. Briddell RA, Hartley CA, Smith KA, McNiece IK. Recombinant rat stem cell factor synergizes with recombinant human granulocyte colony-stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential. Blood 1993; 82: 1720.
31. Laterveer L, Lindley IJD, Hamilton MS, Willemze R, Fibbe WE. Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. Blood 1995; 85: 2269.
32. Lord BI, Woolford LB, Wood LM, et al. Mobilization of early hematopoietic progenitor cells with BB-10010: a genetically engineered variant of human macrophage inflammatory protein-1α. Blood 1995; 85: 3412.
33. Monaco AP, Wood ML, Gottschalk R, Seiler FR. Effect of granulocyte-macrophage colony-stimulating factor on the induction of unresponsiveness by lymphoid cells. Transplantation 1991; 51: 213.
34. Brasel K, McKenna HJ, Morrissey PJ, et al. Hematological effects of Flt3 ligand in vivo in mice. Blood 1996; 88: 2004.
35. Veiby OP, Jacobsen FW, Cui L, Lyman SD, Jacobsen SEW. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential: suppression of apoptosis and counteraction by TNF-α and TGF-β. J Immunol 1996; 157: 2953.
36. Rasko JEJ, Metcalf D, Rossner MT, Begley CG, Nicola NA. The flt3 / flk-2 ligand: receptor distribution and action on murine haemopoietic cell survival and proliferation. Leukemia 1995; 9: 2058.
37. Matthews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 1991; 65: 1143.
38. Li CL, Johnson GR. Murine hematopoietic stem and progenitor cells: I. Enrichment and biological characterization. Blood 1995; 85: 1472.
39. Winton EF, Bucur SZ, Bray RA, et al. The hematopoietic effects of recombinant human (rh) FLT3 ligand administered to non-human primates [Abstract]. Blood 1995; 86: 424a.
40. Papayannopoulou T, Nakamoto B, Lyman S. Mobilization of lymphoid/myeloid hemopoietic progenitors in primates treated with flt3/flk2-ligand [Abstract]. Blood 1995; 86: 423a.
41. Lynch DH, Andreasen A, Miller RE, Schuh JCL. Flt3 ligand: a novel dendritic cell (DC)-stimulating cytokine that induces tumor regression and anti-tumor immune responses in vivo [Abstract]. Blood 1996; 88 (suppl 1) 437a.
42. -) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 1995; 60: 1539.
43. Rastellini C, Lu L, Ricordi C, Starzl TE, Rao AS, Thomson AW. GM-CSF stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 1995; 60: 1366.
44. -) prolong cardiac allograft survival in non-immunosuppressed recipients. Transplantation 1996; 62: 659.
45. Süss G, Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J Exp Med 1996; 183: 1789.
46. Kronin V, Winkel K, Süss G, et al. A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production. J Immunol 1996; 157: 3819.
47. Vremec D, Lieschke GJ, Dunn AR, et al. The influence of granulocyte-macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. Eur J Immunol 1997; 27: 40.